drugset / Trial / NCT02333513
A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation
NaSingle-groupOpen-labelTreatment
Summary
This trial is aimed at evaluating the safety and effectiveness of PCV chemotherapy in patients with recurrent high-grade glioma with IDH1/2 mutation.
Timeline
- Start
- 2015-02
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lomustine | Small molecule | — | — |
| Subject | Vincristine | Small molecule | — | — |
| Subject | procarbazine | Small molecule | — | — |